Clinical Studies Search

Protocol Summary


Protocol No.
PSCI-21-187
Prinicipal Investigator
Shipley, Joshua
Phase
Phase III
Age Group
Adult
Scope
National
Secondary Protocol No.
20321
Title
An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer-sponsored studies
Objective
Primary Objective: Continuation of treatment, Safety
Secondary Objective: Documentation of tolerability
Applicable Disease Sites
Prostate
Status
Open
Participating Institutions
Andrews Patel